Phentermine Hydrochloride

Quick links

Choose a section

Quick links to important sections

Advertisements

Phentermine Hydrochloride

Selected form

Advertisements
Advertisements
Advertisements

Overview of Phentermine Hydrochloride

Property Description
Active ingredient Phentermine
Form Capsule or Tablet (including extended-release)
Pharmacological class Sympathomimetic Amine Anorectic
Common purpose Short-term weight reduction
Origin Synthetic compound

What Type of Medicine is Phentermine Hydrochloride?

Phentermine Hydrochloride is a synthetic, prescription medication classified as a sympathomimetic amine anorectic agent. This classification means the medicine is chemically designed to reduce appetite, functioning as the hydrochloride salt form of the active compound, phentermine. The medication's general use is clinically recognized as a pharmacological tool to support short-term weight reduction when combined with diet and exercise. As a centrally acting agent, its pharmacological class places it within the group of medications that influence the central nervous system (CNS) to modulate appetite signals. It is an atypical stimulant, chemically related to the amphetamine family, although its therapeutic focus is strictly centered on controlling food intake.


Understanding Phentermine's Core Mechanism and Composition

The primary mechanism by which phentermine works is through appetite suppression, which it achieves by acting as a monoamine releasing agent in the brain. This action stimulates the release of specific chemical messengers, principally norepinephrine, which helps to create a sustained feeling of satiety or fullness. Phentermine Hydrochloride is a purely synthetic substance. It is manufactured for oral administration and is supplied either as a single-entity product, containing only phentermine, or as a combination product (such as with topiramate), offering flexibility in patient-specific management strategies.


Available Forms: Capsule, Tablet, and Single-Entity Use

Phentermine Hydrochloride is commercially available as both capsules and various types of tablets, including extended-release and orally disintegrating formulations. These preparations are structurally composed of the active substance, phentermine hydrochloride, combined with pharmaceutical excipients, designed for proper delivery. The availability in different dosage forms allows for varied release profiles, but the core therapeutic role remains consistent: to serve as a short-term adjunct therapy for patients managing exogenous obesity by limiting caloric intake. A differentiating factor for various forms is the rate of release, allowing healthcare providers to select the most appropriate delivery method for a patient's daily routine.

Regulatory References

  1. Phentermine: MedlinePlus Drug Information
Advertisements

What side effects are possible with Phentermine Hydrochloride?

Possible Side Effects and Safety Information

The official safety characteristics and potential adverse reactions of phentermine hydrochloride are classified based on the affected organ system, as documented in regulatory prescribing information by government authorities. The safety profile is structured around high-level categories that define the nature and context of potential risks.

System-Organ-Class Adverse Reactions

Adverse events are documented across several physiological systems. Cardiovascular effects include palpitation, tachycardia (fast heart rate), and elevation of blood pressure. Central Nervous System (CNS) effects include overstimulation, restlessness, insomnia, dizziness, tremor, and headache. Gastrointestinal effects include dryness of the mouth, unpleasant taste, diarrhea, and constipation. Endocrine effects include impotence and changes in libido.

Serious Adverse Reactions and Classifications

Phentermine is associated with the rare risk of serious cardiorespiratory adverse reactions. These include Primary Pulmonary Hypertension (PPH), which is progressive and frequently fatal, and regurgitant cardiac valvular disease, involving structural issues with heart valves. Rare cases of psychotic episodes have been documented, and ischemic events are also listed as a safety concern.

Safety Constraints and Special Populations

Regulatory documents classify phentermine as a Schedule IV controlled substance due to the risk of abuse and dependence. Tolerance to the appetite-suppressing effect may develop within a few weeks, and abrupt cessation following prolonged high-dosage administration can result in withdrawal symptoms, including extreme fatigue and mental depression. The medication's safety and effectiveness have not been established for pediatric patients. Caution is advised in geriatric patients due to substantial renal excretion and in patients with even mild hypertension due to the risk of increased blood pressure.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Phentermine Hydrochloride is documented in regulatory sources as a serious event that requires immediate medical attention. The official overdose profile is defined by a progression of severe effects primarily impacting the central nervous system (CNS) and the cardiovascular system.

Initial manifestations of acute intoxication often involve signs of CNS overstimulation, including restlessness, tremor, hyperreflexia, confusion, hallucinations, and panic states. This initial excitement phase may be followed by symptoms of fatigue and depression. Gastrointestinal complaints such as nausea, vomiting, and abdominal cramps are also listed.

Severe or life-threatening outcomes include acute cardiovascular instability, specifically severe hypertension or hypotension, tachycardia, and potentially life-threatening arrhythmias leading to circulatory collapse. The most critical neurological manifestations are convulsions and coma, which are associated with the risk of fatal poisoning.

The mandated response for overdose management is symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known. Procedures such as gastric lavage and the use of sedatives may be employed to manage severe excitement or agitation. Due to the risk of severe cardiovascular and neurological complications, contact emergency services immediately if an overdose is suspected.

Advertisements

Therapeutic Uses of Phentermine Hydrochloride

Phentermine is considered relevant in clinical settings that involve Exogenous Obesity, a condition characterized by periods of heightened symptoms in adults with significant excess weight. It may be part of symptomatic management when short-term symptomatic assistance is needed in a weight reduction program based on diet and exercise. It is applicable within clinical settings that involve acute or disruptive symptom patterns linked to significant excess weight, often when Body Mass Index and associated health risks meet specific clinical criteria.

It is primarily used to help with symptom clusters that may become intense or disruptive, particularly excessive appetite and difficulty achieving satiety (the feeling of fullness). The supportive relief offered assists with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods while attempting a reduced-calorie diet. It is relevant when supportive symptom management is appropriate during the initial, challenging phases of a weight reduction regimen.

“The primary therapeutic role is to provide supportive relief during the initial, challenging phases of dietary adjustment.”


Quick Fact: Relief for Excessive Appetite

The support provided helps ease the overall symptom burden, which is relevant in contexts involving a heightened systemic burden associated with caloric restriction.

Regulatory References

  1. NIH DailyMed Drug Information
Advertisements

Eligibility and Restrictions for Use

Official Eligibility for Phentermine Hydrochloride

Regulatory documents define strict population eligibility for Phentermine Hydrochloride. Use is generally restricted to adult patients who meet specific Body Mass Index (BMI) criteria: individuals with a BMI of 30 kg/m^2 or greater (obese), or those with a BMI of 27 kg/m^2 or greater when a weight-related comorbidity (e.g., controlled diabetes or hypertension) is present. Safety and efficacy have not been established in pediatric patients typically under the age of 16 or 17.


Absolute Contraindications

Use is contraindicated (must not be used) for several populations due to significant risk, including:

  • Patients with a history of cardiovascular disease (e.g., coronary artery disease, severe hypertension, arrhythmias).
  • Individuals with conditions such as symptomatic hyperthyroidism or glaucoma.
  • Patients in an agitated state or those with a history of drug abuse.
  • Women who are pregnant (Category X) or breastfeeding.
  • Concurrent use, or use within 14 days, of a Monoamine Oxidase Inhibitor (MAOI).

Restricted or Conditional Use

Dose selection and use require caution for older adults (geriatric patients) and in cases of renal or hepatic impairment, acknowledging potential reduced organ function. Patients with mild hypertension also require careful management.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documents define the interaction profile of Phentermine Hydrochloride primarily through high-risk pharmacodynamic effects.


Interaction Profile Overview

Category Officially Documented Interactions
Contraindicated Combination Monoamine Oxidase Inhibitors (MAOIs). Use is formally prohibited due to the risk of a hypertensive crisis.
Timing Restriction Phentermine is contraindicated during or within 14 days following the administration of an MAOI.
Pharmacodynamic Effects May decrease the hypotensive effect of Adrenergic Neuron Blocking Drugs. Requirements for Insulin and Oral Hypoglycemic Medications may be altered.
Co-Administration Restrictions Co-administration is not recommended with Serotonergic Agents or other drug products for weight loss (including prescribed, over-the-counter, and herbal preparations). This restriction includes Fenfluramine and Dexfenfluramine.

Substance and Context Restrictions

Co-administration with alcohol may result in an adverse drug reaction and is restricted. The official regulatory labeling does not formally specify interaction-related risk as being heightened in a specific patient population group, nor does it detail pharmacokinetic interactions based on CYP enzyme or transporter mechanisms.


The interaction structure is dominated by the strict prohibition and timing constraint associated with the MAOI class. These label-based classifications establish mandatory separation requirements and restrictions on use with other medicines and substances that affect the cardiovascular system and blood glucose regulation.

Advertisements

Mechanism of Action

How Phentermine Hydrochloride Works: Pharmacodynamic Mechanism

Phentermine is an indirect-acting sympathomimetic amine that functions by modulating specific monoamine transporters in the central nervous system (CNS), primarily the Dopamine Transporter (DAT) and Norepinephrine Transporter (NET). It acts as a substrate for these transporters and for Vesicular Monoamine Transporter 2 (VMAT2), causing the release of stored norepinephrine (NE) and dopamine (DA) into the synaptic cleft. This action also inhibits the reuptake of these monoamines. The resulting increase in NE and DA availability occurs within the hypothalamus, the brain region regulating appetite and energy balance. The surge stimulates anorexigenic (appetite-suppressing) signaling pathways, resulting in anorexia (appetite suppression).

Separately, the elevated NE levels activate the Sympathetic Nervous System (SNS). This systemic activation results in defined physiological effects, including an elevated heart rate, higher blood pressure, and an increased basal metabolic rate (thermogenesis).

Advertisements

Dosage and Administration Information

Phentermine hydrochloride is administered exclusively via the oral route using its available capsule, tablet, or orally disintegrating tablet (ODT) formulations. The use of the medicine is designated as short-term adjunct therapy, officially limited to a duration of a few weeks.

Dosage and Administration Scheduling

Dosing must be individualized to achieve the lowest effective amount for an adequate response. The standard adult dose ranges from 15 mg to 37.5 mg daily. This dose is generally taken once in the morning, typically administered before breakfast or one to two hours after breakfast.

An alternative regimen involves a low-dose tablet (8 mg), which is administered up to three times daily, taken approximately 30 minutes before each meal. Regardless of the schedule, late evening administration must be avoided.

Administration Rules and Procedural Constraints

For proper administration, certain procedural constraints apply: non-disintegrating capsules and tablets are intended to be swallowed whole. Specialized extended-release or orally disintegrating forms must not be crushed, cut, or chewed.

Population-Specific Rules

The medicine is not recommended for use in patients 16 years of age and under. High-level administration limits are specified for patients with severe renal impairment (eGFR 15 to 29 mL/ min/1.73 m^2), for whom the maximum dosage should be limited to 15 mg daily.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Phentermine Hydrochloride

This overview summarizes the available research base for phentermine, focusing on the types of studies conducted and what their findings indicate, without offering any medical or treatment advice.


Evidence for Use in Exogenous Obesity

The research on phentermine monotherapy has evaluated the context of Exogenous Obesity, a condition conditions involving periods of heightened symptoms related to significant excess weight. The primary research consists of short-term Randomized Controlled Trials (RCTs). These studies research examined how people with high Body Mass Index (BMI ge 30 kg/m^2) or those who were overweight (BMI ge 27 kg/m^2) with associated health issues responded to phentermine when it was added to a foundational program of diet, caloric restriction, and physical activity.

These trials studies explored outcomes related to systemic or functional imbalance by measuring changes in body weight and the percentage of weight lost over the observation period. They also research examined whether participants reached certain weight loss goals—such as reducing body weight by 5% or 10%. Compared to participants who received a placebo (the comparator group) while still following the same diet and exercise plan, the findings describe patterns observed in the studies where participants taking phentermine data show patterns related to measurements of body weight reduction during the brief study intervals.


Short-Term Outcomes Examined in Clinical Trials

The research studies monitored outcomes in addition to overall weight change. They research examined outcomes related to systemic or functional imbalance, such as shifts in cardiometabolic biomarkers. These included measurements of blood pressure (both systolic and diastolic) and changes in lipid profiles (fats in the blood).

Across various analyses, changes in these secondary measurements were observed. However, the evidence quality varies across studies, with reported measurements of shifts in health biomarkers like cholesterol or blood pressure observed in some studies but not always consistent or uniform across the entire research base.


Long-Term Studies and Follow-Up Data

The research available data for certain groups remain insufficient when considering the long-term use of phentermine as a monotherapy. While some clinical and observational studies explored participants for intermediate periods (up to 12 to 24 weeks), and occasionally longer, there is limited information for long-term outcomes that fully characterize the durability of the observed short-term changes.

The long-term effects are not fully established regarding outcomes related to sustained weight management or how long any observed changes persist after the short-term course of medication is completed. Therefore, the certainty remains low when projecting the results of the initial trials over years. Research is ongoing to provide context for long-term data concerning this medicine.


Evidence in Specific Patient Populations

The initial clinical trials research examined a defined population of adults who met specific criteria for high BMI. Additionally, the research included people with conditions where symptoms may vary in intensity, such as those who were overweight but also had certain associated medical conditions like controlled hypertension or type 2 diabetes. These specific populations were included in the research to examine outcomes within these subgroups.

However, the data for certain groups remain insufficient. For instance, limited information for long-term outcomes is available for older adults, and trials focused on specific disease severity or other subgroup findings are uncertain.


Research Gaps and Areas of Uncertainty

A central limitation noted in the scientific literature is the short duration of the core clinical trials used for regulatory review. Because the follow-up durations were limited, the research provides context but not individual predictions about the potential for long-term weight management.

The evidence is limited when attempting to draw conclusions about the effects of phentermine monotherapy over periods exceeding several months. Scientific reports highlight that evidence quality varies across studies regarding secondary outcomes, and there is a recognized need for more extensive research. Comparative evidence is lacking to fully contextualize phentermine within the modern landscape of pharmacological weight management. The findings describe group patterns, not personal outcomes, and the research highlights what is known—and what is still uncertain—about this medication.

Key Studies & References

  1. ADIPEX-P (phentermine hydrochloride) capsule drug label
  2. Phentermine (Drug Information)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Phentermine Hydrochloride (FAQ)

Q: Is Phentermine Hydrochloride the same as phentermine?

Phentermine hydrochloride is the hydrochloride salt form of the active compound, phentermine. The hydrochloride is added to the active ingredient to create the prescription medicine. According to official documents, the medicine is classified as a sympathomimetic amine anorectic, which means it is chemically designed to work by suppressing appetite.

Q: Can Phentermine Hydrochloride be used by people with high blood pressure?

Official eligibility guidelines state that phentermine hydrochloride is contraindicated (must not be used) in patients with a history of severe high blood pressure (hypertension) or other cardiovascular diseases. However, the official prescribing information notes that individuals with mild high blood pressure may require careful management and close monitoring by a healthcare professional during use.

Q: Are there any common foods or drinks that should be avoided when taking this medication?

Regulatory documents state that co-administration with alcohol may result in an adverse drug reaction and is therefore restricted. Beyond this restriction, official labeling does not specify common foods that must be avoided while using this medication.

Q: Do older adults (senior citizens) commonly use Phentermine Hydrochloride?

Official information indicates that caution is necessary when prescribing this medicine to older adults (geriatric patients) due to the potential for reduced organ function, particularly kidney function. Research evidence on the long-term outcomes for older adults using phentermine is also recognized as limited. Regulatory guidance advises caution in the use of this medicine for this population.

Q: Is a dry mouth a frequent side effect reported by users?

Dry mouth is one of the gastrointestinal effects documented in the official safety information for phentermine hydrochloride. While the official labeling lists the occurrence of dry mouth, it does not explicitly provide data on the exact frequency or incidence (how common it is) for this specific side effect.

Q: Do regulatory agencies classify this medicine as high risk?

The medicine is classified by the US Drug Enforcement Administration as a Schedule IV controlled substance due to the potential for dependence and abuse. Furthermore, regulatory documents contain serious warnings regarding the rare risk of cardiorespiratory adverse events, such as Primary Pulmonary Hypertension, which is a critical safety concern.

Q: Can Phentermine Hydrochloride be used if I am currently taking an antidepressant?

Official prescribing information advises against the co-administration of phentermine with serotonergic agents. Serotonergic agents are a class of drugs that affect the brain chemical serotonin, which includes certain types of antidepressants. The official documentation emphasizes the importance of informing a healthcare professional about all current medications.

Q: Is it normal to feel more energetic when first starting this medication?

As a sympathomimetic amine, phentermine works by activating the sympathetic nervous system, which can result in effects like an increased heart rate and blood pressure. The official safety information documents Central Nervous System (CNS) effects such as overstimulation and restlessness, which are effects associated with the drug's activity as a stimulant.

Q: Are there common household products that interact with this drug?

The official product labeling specifically restricts the co-administration of phentermine hydrochloride with alcohol. It does not provide explicit information regarding interactions with other common, non-medical household products.

Q: How quickly do people generally start to notice an effect from the medicine?

Phentermine is an indirect-acting sympathomimetic designed to modulate chemical messengers in the brain that regulate appetite. The dosing schedule is structured to align with mealtimes, taken once daily in the morning or up to three times daily before meals. This scheduling suggests the medicine is used to support appetite control proximate to mealtimes.

Q: How long does the effect of one dose typically last in the body?

According to official pharmacokinetic data, the biological half-life of phentermine is long, ranging from approximately 16 to 31 hours. This long duration means that the medicine is eliminated slowly from the body over an extended period after a single dose.

Q: Can Phentermine Hydrochloride affect the results of a drug test?

Phentermine belongs to a class of drugs chemically and pharmacologically related to amphetamines. This chemical similarity means that the use of phentermine hydrochloride may cause a positive result on initial drug screening tests for amphetamines, often requiring further, more specific testing for accurate confirmation.

Q: Are there special considerations for using this medicine in hot weather?

As a CNS stimulant, phentermine may interfere with the body's natural ability to regulate temperature by reducing the ability to sweat. Due to this potential effect, caution is generally indicated to prevent heat-related illness when engaging in physical activity or exposure to hot environments.

Q: How long after stopping the medicine do its effects usually disappear?

Official pharmacokinetic data indicates the drug has a long half-life of up to 31 hours. This long elimination rate suggests that the medicine will be present in the body and its effects could be felt for several days after a patient stops taking the last dose.

Q: Are there differences between the various brand names of phentermine hydrochloride?

Phentermine hydrochloride is supplied in various forms, including immediate-release tablets, capsules, and extended-release formulations. A primary difference among these forms is the rate of release at which the medicine is released into the body, which can affect the duration of its effect.

Q: Is it safe to drive or operate machinery while on this medication?

The official prescribing information includes a warning that this medicine may cause dizziness or other Central Nervous System (CNS) effects that could impair mental alertness, judgment, or motor skills. The official prescribing information contains a warning against performing tasks that require complete mental attention, such as driving a vehicle or operating heavy machinery.

Q: Are there special monitoring requirements while taking this drug?

Due to potential risks, official guidance requires specific patient monitoring. This includes checking for symptoms of serious conditions like Primary Pulmonary Hypertension and heart valve disease. Patients with pre-existing conditions like diabetes or renal impairment also require close monitoring, often needing adjustments to their other medications.

Q: Is the medication designed to be used by both men and women?

The official product information indicates that the drug is approved for use in adults, regardless of sex. The only sex-specific warnings or contraindications relate to its mandatory exclusion during pregnancy and breastfeeding.

Q: What is the recommended approach if a side effect is noticed?

Official patient counseling information outlines the requirement to seek medical advice immediately if a patient experiences new or worsening symptoms of serious adverse reactions, particularly those affecting the heart and lungs, or any change in vision. Patients are also generally advised to contact a healthcare professional about other side effects.

Q: How does the classification of this drug compare to other appetite suppressants?

Phentermine is classified as a Sympathomimetic Amine Anorectic, meaning it acts as a stimulant on the central nervous system to suppress appetite. Unlike many non-stimulant weight-loss medicines, it is also classified as a Schedule IV controlled substance due to the potential for abuse and dependence.

Q: Are there known issues with taking this medicine while traveling?

As a Schedule IV controlled substance, phentermine hydrochloride is subject to specific regulations concerning possession and transportation. Patients are generally advised to keep controlled substances in their original prescription container and note that travel with controlled substances may require awareness of regulations in the destination country or state.

Q: Why is the medicine sometimes described using its chemical class?

Phentermine is chemically described as a sympathomimetic amine, which is its official pharmacological class. The medicine is described this way because all drugs in this class share a similar mechanism of action that involves stimulating the central nervous system and suppressing appetite.

Q: Do different dosages of Phentermine Hydrochloride have different side effect profiles?

Official regulatory guidance limits the maximum dosage for certain vulnerable populations, such as those with severe renal impairment, to a lower dose of 15 mg daily. In general, official information suggests that higher exposure to the drug, which may occur at higher doses, is associated with a greater risk of experiencing side effects.

Q: Can this medication lead to changes in vision?

Official safety information lists visual disturbances, including blurred vision, as a documented adverse effect. The official label advises that a healthcare provider should be contacted immediately if a patient experiences any change in vision, as it may signal a serious underlying condition.

Advertisements

How should Phentermine Hydrochloride be stored and disposed of?

Phentermine hydrochloride must be stored in specific conditions to maintain product integrity and prevent misuse, as mandated by official labeling.

Storage Conditions

Requirement Official Regulatory Mandate
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F)
Protection Keep away from heat, moisture, and direct light; must be kept from freezing
Container Store in a tight, light-resistant container and keep it tightly closed
Child Safety Store out of the reach of children and in a safe place to prevent theft or abuse

Disposal Instructions

Official instructions require that outdated or unused phentermine should not be kept.

To dispose of the product correctly, patients are directed to ask a healthcare professional or pharmacist how to properly dispose of the unused medicine. This ensures disposal adheres to necessary pharmaceutical waste regulations for controlled substances.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Phentermine Hydrochloride found in:

A-Z Index: